Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice

被引：0

作者：

Curry, Michael ^{[1
]}

Bae, Ho ^{[2
]}

Dieterich, Douglas ^{[3
]}

Ankoma-Sey, Victor ^{[4
]}

Reddy, Rajender ^{[5
]}

Pan, Calvin ^{[6
]}

Hann, Hie-Won ^{[7
]}

Tong, Myron ^{[8
]}

Kim, W. Ray ^{[9
]}

Kwo, Paul ^{[9
]}

Frazier, Lynn ^{[10
]}

Milligan, Scott ^{[11
]}

Spitz, Keith ^{[11
]}

Afdhal, Nezam ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[2] Asian Pacific Liver Ctr, St Vincent Med Ctr, Los Angeles, CA USA

[3] Mt Sinai Sch Med, New York, NY USA

[4] Liver Associates Texas PA, Houston, TX USA

[5] Univ Penn, Philadelphia, PA 19104 USA

[6] NYU, Sch Med, Langone Hlth, New York, NY USA

[7] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[8] Huntington Med Res Inst, Liver Ctr, Pasadena, CA USA

[9] Stanford Univ, Sch Med, Stanford, CA USA

[10] Liver Wellness Ctr, Little Rock, AR USA

[11] Trio Hlth Analyt, La Jolla, CA USA

来源：

关键词：

D O I：

10.1016/S0618-8278(19)30912-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-167

引用

页码：E462 / E462

页数：1